Switch to:
More From Other Websites
Novogen Completes the Private Placement of Equity Apr 29 2015
Novogen Regains Full Compliance with NASDAQ Listing Rule Apr 27 2015
Novogen Posts Details on Rights Issue Offering for Shareholders Apr 26 2015
Cantrixil Receives Orphan Drug Designation from FDA Apr 21 2015
Novogen (NVGN) Stock Falls Today on Private Placement Apr 21 2015
Novogen taps investors for $30.5m Apr 21 2015
Novogen Conducts Private Placement and Announces Rights Offering to Shareholders Apr 20 2015
Novogen poised for capital raising Apr 20 2015
Cantrixil Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer Apr 20 2015
Novogen (NVGN) Stock Rises Today After Announcing Brain Cancer Treatment Collaboration Apr 17 2015
Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer Apr 16 2015
Novagen (NVGN) Stock Spiked Today on Melanoma Treatment Study Results Apr 09 2015
Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma Apr 08 2015
Novogen Engages Leading US Investor Relations Firm Apr 01 2015
Novogen shares surge on drug data Mar 30 2015
Yale University and Novogen Release Data on Cantrixil Mode of Action Mar 29 2015
Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study Mar 18 2015
Sky News, Helen Dalley interviews Dr Graham Kelly Mar 09 2015
Cantrixil Data to be Presented at Two Major Conferences Mar 06 2015
Novogen Makes Big Step In Fighting Brain Cancer Mar 04 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK